Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 4/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.45 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.39 |
| ▸ | CA12 | O43570 | 2/20 | 0.39 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
| ▸ | CA4 | P22748 | 2/20 | 0.39 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.39 |
| ▸ | CA6 | P23280 | 1/20 | 0.39 |
| ▸ | CA7 | P43166 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | F2 | P00734 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL50746 | 0.83 | HPGD (0.50) | HPGDALDH1A1HSD17B10CYP1A2SMN1; SMN2 | |
| SCHEMBL31020137 | 0.79 | BCAT2 (0.50) | HPGDALDH1A1HSD17B10BCL2L1CYP1A2 | |
| SCHEMBL23709161 | 0.79 | BCAT2 (0.50) | HPGDALDH1A1HSD17B10BCL2L1CYP1A2 | |
| SCHEMBL28794373 | 0.78 | CYP1A2 (0.52) | HPGDALDH1A1HSD17B10CYP1A2SMN1; SMN2 | |
| SCHEMBL29542253 | 0.76 | AKR1C3 (0.55) | HPGDALDH1A1HSD17B10BCL2L1CYP1A2 | |
| SCHEMBL92723 | 0.76 | AKR1C3 (0.55) | HPGDALDH1A1HSD17B10BCL2L1CYP1A2 | |
| Hydrochloric Acid SCHEMBL9156565 | 0.73 | ALDH1A1 (0.43) | HPGDALDH1A1HSD17B10BCL2L1SMN1; SMN2 | |
| SCHEMBL3676607 | 0.73 | HTR7 (0.46) | CYP1A2CA2CA4CA1CA6 | |
| SCHEMBL11085072 | 0.72 | ALDH1A1 (0.50) | HPGDALDH1A1HSD17B10BCL2L1SMN1; SMN2 | |
| SCHEMBL1919550 | 0.72 | ALDH1A1 (0.67) | HPGDALDH1A1HSD17B10BCL2L1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2669342-B1 | ACTIVE-ENERGY-RAY-CURABLE INKJET INK COMPOSITION, ACTIVE-ENERGY-RAY-CURABLE INKJET INK, AND INKJET RECORDING METHOD | KONICA MINOLTA INC (JP) | 2020-03-18 | — | — | EP | disclosed |
| US-9416289-B2 | Active-energy-ray-curable inkjet ink composition, active-energy-ray-curable inkjet ink, and inkjet recording method | Konica Minolta, Inc. (JP) | 2016-08-16 | — | — | US | disclosed |
| EP-2669342-A1 | ACTIVE-ENERGY-RAY-CURABLE INKJET INK COMPOSITION, ACTIVE-ENERGY-RAY-CURABLE INKJET INK, AND INKJET RECORDING METHOD | Konica Minolta, Inc. (JP) | 2013-12-04 | — | — | EP | disclosed |
| US-20130307913-A1 | ACTIVE-ENERGY-RAY-CURABLE INKJET INK COMPOSITION, ACTIVE-ENERGY-RAY-CURABLE INKJET INK, AND INKJET RECORDING METHOD | Konica Minolta, Inc. (JP) | 2013-11-21 | — | — | US | disclosed |
| US-8349916-B2 | Actinic energy radiation curable ink-jet ink, ink-jet recording method, and printed matter | KONICA MINOLTA IJ TECHNOLOGIES, INC. (JP) | 2013-01-08 | — | — | US | disclosed |
| EP-2228415-B1 | Actinic energy radiation curable ink-jet ink, ink-jet recoring method, and printed matter | KONICA MINOLTA IJ TECHNOLOGIES (JP) | 2012-03-21 | — | — | EP | disclosed |
| US-20100255211-A1 | ACTINIC ENERGY RADIATION CURABLE INK-JET INK AND INK-JET IMAGE FORMING METHOD | KONICA MINOLTA IJ TECHNOLOGIES, INC. (JP) | 2010-10-07 | — | — | US | disclosed |
| EP-2236568-A1 | Actinic energy radiation curable ink-jet ink and ink-jet image forming method | Konica Minolta IJ Technologies, Inc. (JP) | 2010-10-06 | — | — | EP | disclosed |
| US-20100233446-A1 | ACTINIC ENERGY RADIATION CURABLE INK-JET INK, INK-JET RECORDING METHOD, AND PRINTED MATTER | KONICA MINOLTA IJ TECHNOLOGIES, INC. (JP) | 2010-09-16 | — | — | US | disclosed |
| EP-2228415-A1 | Acting energy radiation curable ink-jet ink, ink-jet recoring method, and printed matter | Konica Minolta IJ Technologies, Inc. (JP) | 2010-09-15 | — | — | EP | disclosed |
| US-20060287548-A1 | Radical interceptors as stabilizers of polymerizable compounds | BASF AKTIENGESELLSCHAFT (DE) | 2006-12-21 | — | — | US | disclosed |
| CN-1878852-A | Radical trap as a stabilizer for polymerizable compounds | BASF AG (DE) | 2006-12-13 | — | — | CN | disclosed |
| CN-1705872-A | Method for determining the amount of polymer separated from acrylic acid and/or acrylic esters | BASF AG (DE) | 2005-12-07 | — | — | CN | disclosed |
| US-20040082737-A1 | Determination of the amount of polymer deposited from (meth) acrylic acid and/or (meth) acrylic esters | BASF AKTIENGESELLSCHAFT (DE) | 2004-04-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060287548-A1 | Radical interceptors as stabilizers of polymerizable compounds | TTPA, AADAT, TSPO | HPGD 209/4885ALDH1A1 1648/4885HSD17B10 3372/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.